Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
175,353,101
-
Share change
-
+278,705
-
Total reported value
-
$30,518,436,188
-
Put/Call ratio
-
58%
-
Price per share
-
$174.10
-
Number of holders
-
846
-
Value change
-
+$110,838,160
-
Number of buys
-
354
-
Number of sells
-
392
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2018
As of 30 Sep 2018 Edwards Lifesciences Corp - Common Stock (EW) had 846 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 175,353,101 shares of stock of the company.
Largest 10 holders included Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, ALLIANCEBERNSTEIN L.P., BROWN ADVISORY INC, and Capital Research Global Investors.
This table shows 847 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.